Literature DB >> 25936296

Juvenile idiopathic arthritis and physical activity: possible inflammatory and immune modulation and tracks for interventions in young populations.

Emmanuelle Rochette1, Pascale Duché2, Etienne Merlin3.   

Abstract

Juvenile idiopathic arthritis (JIA) is a chronic inflammatory disease characterized by persistent joint inflammation that manifests as joint pain and swelling and limited range of joint motion. In healthy subjects, the literature reports that physical activity has an anti-inflammatory effect. In JIA patients, exercise could be used as a therapeutic tool to counteract disease-related inflammation and thereby improve clinical symptoms, although transient flare of pain could be the price to pay. Indeed, in patients with a chronic inflammatory disease, physical activity is prone to exacerbate underlying inflammatory stress. Physical activity improves quality of life and symptoms in JIA patients, but the mechanisms of action remain unclear. This review focuses on the mechanisms underlying exercise-induced immune and hormonal changes. Data on the impact of acute and chronic physical activities on the secretion of hormones and other molecules such as miRNA or peptides involved in the inflammatory process in JIA was compiled and summarized, and the key role of the biological effect of muscle-derived interleukin 6 in the exercise-induced modulation of pro/anti-inflammatory balance is addressed. We also go on to review the effect of training and type of exercise on cytokine response. This review highlights the beneficial effect of physical exercise in children with JIA and potential effect of exercise on the balance between pro- and anti-inflammatory response.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Calprotectin; Interleukin; Juvenile idiopathic arthritis; Physical exercise; Pro-anti-inflammatory balance; miRNA

Mesh:

Substances:

Year:  2015        PMID: 25936296     DOI: 10.1016/j.autrev.2015.04.007

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  7 in total

1.  Infliximab therapy and outcomes in patients with polyarticular juvenile idiopathic arthritis: a single-center study in China.

Authors:  Da-Wei Liu; Jiao-Jiao Chen; Xue-Mei Tang; Yu Zhang; Juan Zhou
Journal:  World J Pediatr       Date:  2019-10-14       Impact factor: 2.764

2.  Epidemiology and risk of juvenile idiopathic arthritis among children with allergic diseases: a nationwide population-based study.

Authors:  Chien-Heng Lin; Cheng-Li Lin; Te-Chun Shen; Chang-Ching Wei
Journal:  Pediatr Rheumatol Online J       Date:  2016-03-10       Impact factor: 3.054

Review 3.  Mechanisms of vascular comorbidity in autoimmune diseases.

Authors:  György Nagy; Nóra Németh; Edit I Buzás
Journal:  Curr Opin Rheumatol       Date:  2018-03       Impact factor: 5.006

4.  Design and implementation of a decision aid for juvenile idiopathic arthritis medication choices.

Authors:  William B Brinkman; Ellen A Lipstein; Janalee Taylor; Pamela J Schoettker; Katherine Naylor; Karla Jones; Sheetal S Vora; Catherine C Mims; Elizabeth Roth-Wojcicki; Beth Gottlieb; Nancy Griffin; Carole Lannon; Esi Morgan
Journal:  Pediatr Rheumatol Online J       Date:  2017-06-05       Impact factor: 3.054

5.  Health-related quality of life among Swedish children with Juvenile Idiopathic Arthritis: parent-child discrepancies, gender differences and comparison with a European cohort.

Authors:  Veronica Lundberg; Catharina Eriksson
Journal:  Pediatr Rheumatol Online J       Date:  2017-04-12       Impact factor: 3.054

6.  Regulation of JAK/STAT signal pathway by miR-21 in the pathogenesis of juvenile idiopathic arthritis.

Authors:  Hong-Wei Li; Hua-Song Zeng
Journal:  World J Pediatr       Date:  2019-10-22       Impact factor: 2.764

7.  Proteomics based markers of clinical pain severity in juvenile idiopathic arthritis.

Authors:  Hanne Van Der Heijden; Benoit Fatou; Diana Sibai; Kacie Hoyt; Maria Taylor; Kin Cheung; Jordan Lemme; Mariesa Cay; Benjamin Goodlett; Jeffery Lo; Melissa M Hazen; Olha Halyabar; Esra Meidan; Rudy Schreiber; Camilo Jaimes; Kirsten Ecklund; Lauren A Henderson; Margaret H Chang; Peter A Nigrovic; Robert P Sundel; Hanno Steen; Jaymin Upadhyay
Journal:  Pediatr Rheumatol Online J       Date:  2022-01-15       Impact factor: 3.413

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.